about
Assessment of left ventricle function in aortic stenosis: mitral annular plane systolic excursion is not inferior to speckle tracking echocardiography derived global longitudinal peak strain.Safety of embolic protection device-assisted and unprotected intravascular ultrasound in evaluating carotid artery atherosclerotic lesionsPerfusion myocardial scintigraphy as a method of qualification and control for percutaneous transmyocardial laser revascularization in patients with end-stage coronary artery disease.[Left ventricular systolic function in patients with refractory angina pectoris treated with percutaneous myocardial laser revascularisation, results of long-term follow-up].[Quality of life in patients after implantation of pacemaker type DDD]Comparison of two European models estimating risk of -sudden cardiac death in hypertrophic cardiomyopathy.The benefit of atrial septal defect closure in elderly patients.Is it worth closing the atrial septal defect in patients with insignificant shunt?Carotid artery stenting according to the tailored-CAS algorithm is associated with a low complication rate at 30 days: data from the TARGET-CAS study.Development, implementation, and multicenter clinical validation of the TeleDICOM--advanced, interactive teleconsultation system.Markers of thrombogenesis and fibrinolysis and their relation to inflammation and endothelial activation in patients with idiopathic pulmonary arterial hypertension.Coronary microcirculation and reperfusion failure. Do we know what diagnostic tools we have?Influence of chronic inflammation and autoimmunity on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patientsInfluence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled studyReactivity of pulmonary circulation and right ventricle function to inhaled nitric oxide in systemic sclerosis patientsRelationship between mitral leaflets angles, left ventricular geometry and mitral deformation indices in patients with ischemic mitral regurgitation: imaging by echocardiography and cardiac magnetic resonanceMyocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study.Cardiac Rehabilitation in Real Life.Treatment strategies in severe symptomatic carotid and coronary artery diseaseAssessment of left ventricle function in patients with symptomatic and asymptomatic aortic stenosis by 2-dimensional speckle-tracking imagingMultimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosisFibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension.Arterial stiffness in adult patients after Fontan procedure.Impact of Chlamydia pneumoniae infection on survival rate after heart transplantation.Rare cardiovascular diseases: from European legislations to classification and clinical practice.Knowledge of rare diseases among health care students – the effect of targeted educationEffects of endogenous cardioprotective mechanisms on ischemia-reperfusion injury.Transradial approach for carotid artery stenting in a patient with severe peripheral arterial disease.Secondary prevention in patients after hospitalisation due to coronary artery disease: what has changed since 2006?Novel PARADIGM in carotid revascularisation: Prospective evaluation of All-comer peRcutaneous cArotiD revascularisation in symptomatic and Increased-risk asymptomatic carotid artery stenosis using CGuard™ MicroNet-covered embolic prevention stent syKnowledge of a patient-dependant phase of acute myocardial infarction in Polish adults: the role of physician's advice.The prevalence of abnormal echocardiographic findings in a sample of urban adult population.Assessment of knowledge on cardiovascular disease risk factors by postal survey in residents of Małopolska Voivodeship. Małopolska CArdiovascular PReventive Intervention Study (M-CAPRI).Effectiveness of single medical advice on emergency phone number knowledge in urban adult population--"Health, Alcohol and Psychosocial Factors in Eastern Europe" substudy.Knowledge of cardiovascular disease risk factors and the risk of death in middle-aged residents of Krakow.[Lyme carditis].[A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population].Atrioventricular Conduction Delay Predicts Impaired Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction.Clinical response to calcium channel blockers in a hemodynamically unstable patient with reactive idiopathic pulmonary arterial hypertension.
P50
Q30444804-0D2F42D6-8DAC-456F-9FF1-C9A1C31723F6Q30455282-563E1A2A-3C41-4A3B-9742-A2B002BAE0CEQ30828539-FAC260A8-713A-4A87-9692-89BF4F82AC85Q31148961-BC8D3D4F-4E16-4E19-92A6-1A537BB9D55EQ33145890-EF36234D-06B7-48E8-99C7-70410866AA19Q33168882-3B25721F-7369-465D-ADD6-EAF4AF147147Q33933822-A2DB2BAF-A0D9-4B95-82AD-3ED1D2816535Q33941305-7C8CA9B1-D4E9-4E81-AC36-9020DF4AD74DQ34243299-CC5B66DF-CDED-45CF-9B3B-C828DF6FB5B2Q34970969-13CDCD04-F3D3-4A93-8507-7BE0FDD95240Q35061559-C944B8AB-8A2E-4538-99D5-1E677D6EC011Q35115144-FCDAB721-2E85-435B-B52C-F8D294FB7383Q35209597-3EBCED71-7D7C-4987-96BB-F8FEF544232AQ35617640-79E490DB-CD9C-4202-8F0B-761DB700FEE3Q35644221-5800ABC3-904B-480E-8469-E6FD9258B3E1Q35745566-5F21A18D-C6BB-4DF3-94B8-6E54DA9C3750Q35829154-E0063B9A-E8B0-48CD-85A9-8BEBE767C5D2Q36195105-7FE19EA9-02FE-4160-BB33-C4E320B1AE26Q36516672-9A4D726D-4D7A-4041-B155-B534EB9F7A2DQ36577610-1DC55751-A476-4489-ADD6-FF906FCF6AC7Q37043341-50210E23-8380-41E5-B8C3-59D7C1C2977AQ37358560-0937EB7F-E246-46F2-BD0D-CCDF31446748Q37642747-FD2F71EC-3AD5-4A13-AE52-95572107F941Q37710554-B06F82CD-F88D-4460-ADD7-6FD0A6ABF4CBQ37870063-E8FB9259-0668-4BC9-8256-D3F3B0EB4D00Q38265130-089ED2DF-7208-479E-9DCD-CF3095EBDA22Q38662452-B3343209-A71F-491F-9C4C-685B6B57E4D6Q39128094-EA783634-1384-4671-BDDE-D7E3D52EBCC3Q39142451-1BAFF56E-F14B-4778-9322-8DE49CD40106Q39275815-199E34B8-A4AD-4AA4-945C-18A365DB5C95Q39765369-DE275DFF-A6ED-41D5-9F2B-3209504AD9C2Q39946058-AE883E91-466F-46F3-9AA9-93895ACDA202Q40133973-00CFBA64-80D0-4A90-93BD-7004AF62B48FQ40140128-4B2E9878-6DD3-4EDE-AE30-00FF79756A74Q40326604-123E2E9E-134E-44DB-99A0-6F833684D3D0Q40416631-1F023806-60EA-42B1-93BA-CE26EF370E43Q41026528-CDF6C046-307F-4AC6-9391-6F6D31BBC17DQ41161581-563DE362-EC61-4FC3-81E8-F27E1CB83DDFQ41529975-11FC70BF-D389-478F-9F52-647ECC3B4899Q41925529-B6CD6025-775B-4E97-AA5E-27A19D6EB76D
P50
description
polski lekarz, kardiolog
@pl
researcher ORCID ID = 0000-0001-6101-2935
@en
wetenschapper
@nl
name
Piotr Podolec
@ast
Piotr Podolec
@ca
Piotr Podolec
@cs
Piotr Podolec
@en
Piotr Podolec
@es
Piotr Podolec
@ga
Piotr Podolec
@gl
Piotr Podolec
@hr
Piotr Podolec
@hsb
Piotr Podolec
@it
type
label
Piotr Podolec
@ast
Piotr Podolec
@ca
Piotr Podolec
@cs
Piotr Podolec
@en
Piotr Podolec
@es
Piotr Podolec
@ga
Piotr Podolec
@gl
Piotr Podolec
@hr
Piotr Podolec
@hsb
Piotr Podolec
@it
prefLabel
Piotr Podolec
@ast
Piotr Podolec
@ca
Piotr Podolec
@cs
Piotr Podolec
@en
Piotr Podolec
@es
Piotr Podolec
@ga
Piotr Podolec
@gl
Piotr Podolec
@hr
Piotr Podolec
@hsb
Piotr Podolec
@it
P214
P1153
7005646706
P1412
P1559
Piotr Podolec
@pl
P21
P214
P27
P31
P3124
P496
0000-0001-6101-2935
P735
P7859
viaf-101633417